<?xml version="1.0" encoding="UTF-8"?>
<p>There are several limitations in this study. First, since all the serum comes from individuals in Hong Kong, this may not reflect the situation in other places. For example, in some parts of Europe, A(H3N2) was the predominant subtype in the 2018/2019 winter influenza season. Second, we have used a limited number of influenza virus strains. Third, one mutation arose during the virus passage for H3N2-inter. However, for this mutation, the MN titer was the same against T160 or K160 strain when ferrets were infected with a natural strain (T160) of H3N2 [
 <xref rid="ref38" ref-type="bibr">38</xref>]. Since most of the Hong Kong population has not been vaccinated, this should not affect our results substantially.
</p>
